Navigation Links
How nice, brown rice: Study shows rice bran lowers blood pressure in rats

Thousands of years ago, humans began scrubbing off and discarding the outer layer of long-grain rice, preferring the polished white kernel beneath. Now, for the first time, scientists in Japan have shown that this waste product of rice processing, called rice bran, significantly lowers blood pressure in rats whose hypertension resembles that of humans.

The team reports their findings in the March 8 issue of the Journal of Agricultural and Food Chemistry, published by the American Chemical Society, the world’s largest scientific society.

A commonly prescribed class of drugs called ACE inhibitors dilates the arteries of hypertensive patients and thus decreases their risk of stroke, heart attack and kidney disease. But the drugs can also carry side effects: chronic cough, allergic reactions, dizziness, even kidney problems.

What if some component of our diet could work in similar fashion, with few or no side effects? Researchers at Tohoku University and Japan’s National Research Institute of Brewing demonstrated that adding rice bran to the diets of hypertensive, stroke-prone rats lowered the animals?systolic blood pressure by about 20 percent and, via the same mechanism, inhibited angiotensin-1 converting enzyme, or ACE.

“There’s much work being done on various bran fractions to nail down any health benefits,?says the journal’s editor, James Seiber, Ph.D., who is also director of the U.S. Department of Agriculture’s Western Regional Research Center in Davis, Calif. “This particular paper caught my attention for two reasons: the potential of bringing a waste product like rice bran into beneficial use, and the way the group went about their study with good controlled experiments using an appropriate model.?/p>

It’s still not clear whether simply eating more brown rice, which retains some of its bran, would reduce the risk of heart disease. However, previous research in humans, as well as animals with high cholesterol, does sug gest that certain fractions of rice bran can lower levels of unhealthy LDL cholesterol.

The Tohoku study adds antihypertensive activity to the picture, along with a host of other biochemical markers that track blood glucose (implicated in diabetes), lipid profile, kidney function and the harmful effects of free radicals.

For example, high levels of a marker called 8-OHdG indicate biological stress and genetic damage due to oxygen-based free radicals. The researchers found that rice bran, which contains various forms of the antioxidant Vitamin E, markedly lowered the rats?levels of the peptide 8-OHdG.

“Oxidative stress plays an important role in the initiation and progression of cardiovascular diseases,?explained lead author Ardiansyah [editor note: name is correct as written, there is no first name], a Ph.D. candidate at the university’s School of Agricultural Science.

He added one more element to the research that is new: using enzymes to clip components of rice bran from its cell walls, rather than extracting a fraction with ethanol. “I think enzymatic treatment will be more suitable for applications if we’d like to use [rice bran as] functional food,?he said.

The researchers?next step is to elucidate the mechanisms by which specific components of rice bran inhibit ACE and lower cholesterol.


'"/>

Source:American Chemical Society


Related biology news :

1. Chemicals in brown algae may protect against skin cancer
2. A more powerful and efficient engine for rice: the C3-C4 challenge
3. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
4. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
5. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
6. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
7. Study Links Ebola Outbreaks To Animal Carcasses
8. Breakthrough Microarray-based Technology for the Study of Cancer
9. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
10. Study finds more than one-third of human genome regulated by RNA
11. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... -- Delta (NYSE: DAL ) customers now can use fingerprints ... Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington National ... Delta,s biometric boarding pass experience that launched ... into the boarding process to allow eligible Delta SkyMiles Members who are ...
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... a United States multicenter, prospective clinical study that demonstrates the accuracy of ... capable of identifying clinically significant acute bacterial and viral respiratory tract infections ...
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology: